WallStSmart

Hubbell Inc (HUBB)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Hubbell Inc generates 2158% more annual revenue ($5.84B vs $258.90M). HUBB leads profitability with a 15.2% profit margin vs -15.5%. HUBB earns a higher WallStSmart Score of 61/100 (C+).

HUBB

Buy

61

out of 100

Grade: C+

Growth: 6.0Profit: 8.0Value: 8.0Quality: 5.5
Piotroski: 4/9

ZEPP

Hold

43

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HUBBOvervalued (-8.1%)

Margin of Safety

-8.1%

Fair Value

$477.39

Current Price

$480.97

$3.58 premium

UndervaluedFair: $477.39Overvalued

Intrinsic value data unavailable for ZEPP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HUBB1 strengths · Avg: 9.0/10
Return on EquityProfitability
24.5%9/10

Every $100 of equity generates 25 in profit

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

HUBB2 concerns · Avg: 4.0/10
PEG RatioValuation
2.314/10

Expensive relative to growth rate

P/E RatioValuation
30.6x4/10

Premium valuation, high expectations priced in

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$216.30M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : HUBB

The strongest argument for HUBB centers on Return on Equity. Profitability is solid with margins at 15.2% and operating margin at 19.1%. Revenue growth of 11.9% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : HUBB

The primary concerns for HUBB are PEG Ratio, P/E Ratio.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

HUBB profiles as a mature stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.59 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor ELECTRICAL EQUIPMENT & PARTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HUBB scores higher overall (61/100 vs 43/100), backed by strong 15.2% margins and 11.9% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hubbell Inc

INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA

Hubbell Incorporated designs, manufactures, and sells electrical and electronic products in the United States and internationally. The company is headquartered in Shelton, Connecticut.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?